Literature DB >> 3112777

Antithymocyte globulin stimulates human hematopoietic progenitor cells.

A T Huang, N G Mold, S F Zhang.   

Abstract

Antithymocyte globulin (ATG), a horse antihuman thymus antiserum highly effective in the majority of patients with aplastic anemia, was studied for its in vitro effects on hematopoietic progenitor cells. Marrow cells isolated by an immunoadherence technique with the HPCA-1 (human progenitor cell antigen) monoclonal antibody after removal of contaminating T cells and macrophages formed erythroid colonies in methyl cellulose media in the presence of ATG at concentrations of 25-50 micrograms/ml. ATG also stimulated continuous production of hemoglobin-containing erythroid colonies beyond 35 days of culture when it was added to the culture weekly. ATG also had an indirect effect on myeloid (granulocytic and macrophagic) colony growth in vitro. At a concentration of 10 micrograms/ml, ATG stimulated late but not early myeloid progenitor cells to form mature colonies. This effect required the participation of lymphocytes containing the Leu-11 antigen and macrophages or supernatant fluids made from these two types of cells that had been preincubated with ATG for 3 hr and then cultured for 5 additional days. The supernatant fluids produced in such a manner showed characteristics similar to granulocyte colony-stimulating factor and had an activity peak that eluted at a volume corresponding to a 20,000 Da molecular mass protein by high-resolution liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112777      PMCID: PMC298979          DOI: 10.1073/pnas.84.16.5942

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

1.  Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.

Authors:  K F Mangan; L D'Alessandro; M T Mullaney
Journal:  J Lab Clin Med       Date:  1986-04

2.  Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.

Authors:  E Gluckman; A Devergie; A Faille; A J Barrett; M Bonneau; M Boiron; J Bernard
Journal:  Exp Hematol       Date:  1978-09       Impact factor: 3.084

3.  Antithymocyte globulin reacts with many normal human cell types.

Authors:  B Greco; L Bielory; D Stephany; S M Hsu; P Gascon; A Nienhuis; N Young
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

4.  Circulating activated suppressor T lymphocytes in aplastic anemia.

Authors:  N C Zoumbos; P Gascón; J Y Djeu; S R Trost; N S Young
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

5.  Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin.

Authors:  P Gascon; N C Zoumbos; G Scala; J Y Djeu; J G Moore; N S Young
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

6.  Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin.

Authors:  R F Hunter; N G Mold; R B Mitchell; A T Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

  6 in total
  3 in total

1.  Impaired liver function tests in patients treated with antithymocyte globulin: implication for liver transplantation.

Authors:  A Toren; Y Ilan; R Or; J Kapelushnik; A Nagler
Journal:  Med Oncol       Date:  1997 Sep-Dec       Impact factor: 3.064

2.  Anti-thoracic duct lymphocyte globulin stimulates human megakaryocytopoiesis in vitro.

Authors:  K Ogata; K Dan; S Kuriya; T Nomura
Journal:  Blut       Date:  1990-03

3.  Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia.

Authors:  U Köller; W Hinterberger; L Gschwandtler; R Grümayer; O Majdic; W Knapp
Journal:  Blut       Date:  1989-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.